• Home
  • Pipeline
      • Back
      • PTX-COVID19-B
      • PTX-COVID19-LT
      • PTX-101 - Proposed mRNA Cancer Program
  • Technology
  • About
      • Back
      • Meet the Team
      • Foundations of Providence
  • News & Media
      • Back
      • Press Releases
      • Publications
      • Media
  • Business Development & Investors
  • Privacy Policy
  • People & Culture
Privacy PolicyPeople & Culture
Providence Therapeutics
  • Home
  • Pipeline
    • PTX-COVID19-B
    • PTX-COVID19-LT
    • PTX-101 - Proposed mRNA Cancer Program
  • Technology
  • About
    • Meet the Team
    • Foundations of Providence
  • News & Media
    • Press Releases
    • Publications
    • Media
  • Business Development & Investors
  • Privacy Policy
  • People & Culture

Publications

and Scientific Papers

Image
Image
  • All
  • 2022
  • 2021
Preclinical Evaluation of a SARS-CoV-2 mRNA Vaccine PTX-COVID19-B

Preclinical Evaluation of a SARS-CoV-2 mRNA Vaccine PTX-COVID19-B

Written on January 19, 2022

Read more

Providence Therapeutics

Useful Links

Privacy Policy
People & Culture
Linkedin Page

Contact Us

120 - 8832 Blackfoot Trail S.E.
Calgary, AB T2J 3J1
Business Development: 
Investor Relations: 
Media Relations: Veronica Eames, 
© 2023 Providence Therapeutics. All Rights Reserved.
Calgary Web Design by Blue Ocean